NASDAQ:IPHS - Innophos Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $28.33 +0.11 (+0.39 %) (As of 05/22/2019 08:00 AM ET)Previous Close$28.22Today's Range$27.98 - $28.7752-Week Range$22.57 - $50.40Volume199,600 shsAverage Volume110,803 shsMarket Capitalization$557.25 millionP/E Ratio12.43Dividend Yield6.80%Beta1.33 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Innophos Holdings, Inc., together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste. It also provides food and technical grade purified phosphoric acid (PPA) used in the production of phosphate salts, as well as in food and beverages, and water treatment applications; technical grade sodium tripolyphosphate (STPP), a specialty phosphate, which is used as an ingredient in cleaning products, such as industrial and institutional cleaners, automatic dishwashing detergents, and consumer laundry detergents, as well as in water treatment, clay processing, and copper ore processing activities; and detergent grade PPA that is primarily used in the production of STPP. In addition, the company offers granular triple super-phosphate (GTSP), a fertilizer product line used for enhancing crop yields in various agricultural sectors; and merchant green phosphoric acid. It serves primarily consumer goods manufacturers, distributors, and specialty chemical manufacturers in the United States, Canada, Mexico, and internationally. Innophos Holdings, Inc. was founded in 2004 and is headquartered in Cranbury, New Jersey. Receive IPHS News and Ratings via Email Sign-up to receive the latest news and ratings for IPHS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Chemicals & allied products Sub-IndustrySpecialty Chemicals SectorBasic Materials Current SymbolNASDAQ:IPHS Previous Symbol CUSIP45774N10 CIK1364099 Webhttp://www.innophos.com/ Phone609-495-2495Debt Debt-to-Equity Ratio0.95 Current Ratio3.14 Quick Ratio1.49Price-To-Earnings Trailing P/E Ratio12.43 Forward P/E Ratio12.00 P/E GrowthN/A Sales & Book Value Annual Sales$801.84 million Price / Sales0.69 Cash Flow$4.4755 per share Price / Cash Flow6.33 Book Value$17.62 per share Price / Book1.61Profitability EPS (Most Recent Fiscal Year)$2.28 Net Income$36.07 million Net Margins4.30% Return on Equity13.09% Return on Assets5.38%Miscellaneous Employees1,485 Outstanding Shares19,670,000Market Cap$557.25 million Next Earnings Date7/29/2019 (Estimated) OptionableOptionable Innophos (NASDAQ:IPHS) Frequently Asked Questions What is Innophos' stock symbol? Innophos trades on the NASDAQ under the ticker symbol "IPHS." How often does Innophos pay dividends? What is the dividend yield for Innophos? Innophos announced a quarterly dividend on Wednesday, May 1st. Stockholders of record on Friday, May 17th will be paid a dividend of $0.48 per share on Friday, June 7th. This represents a $1.92 annualized dividend and a dividend yield of 6.78%. The ex-dividend date is Thursday, May 16th. View Innophos' Dividend History. How were Innophos' earnings last quarter? Innophos Holdings, Inc. (NASDAQ:IPHS) released its earnings results on Tuesday, April, 30th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.43 by $0.14. The specialty chemicals company earned $191.41 million during the quarter, compared to the consensus estimate of $199.90 million. Innophos had a return on equity of 13.09% and a net margin of 4.30%. The firm's quarterly revenue was down 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.61 earnings per share. View Innophos' Earnings History. When is Innophos' next earnings date? Innophos is scheduled to release their next quarterly earnings announcement on Monday, July 29th 2019. View Earnings Estimates for Innophos. What guidance has Innophos issued on next quarter's earnings? Innophos issued an update on its FY 2019 earnings guidance on Tuesday, April, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $785.96-793.98 million, compared to the consensus revenue estimate of $799.03 million. What is the consensus analysts' recommendation for Innophos? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innophos in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innophos. Has Innophos been receiving favorable news coverage? News articles about IPHS stock have been trending somewhat positive on Wednesday, according to InfoTrie. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Innophos earned a news impact score of 1.4 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of Innophos' key competitors? Some companies that are related to Innophos include PQ Group (PQG), Innospec (IOSP), GCP Applied Technologies (GCP), KMG Chemicals (KMG), Nexeo Solutions (NXEO), Hawkins (HWKN), Liquidmetal Technologies (LQMT), Gulf Resources (GURE), Green Earth Technologies (GETG), KURARAY CO LTD/ADR (KURRY) and OCI Partners (OCIP). What other stocks do shareholders of Innophos own? Based on aggregate information from My MarketBeat watchlists, some companies that other Innophos investors own include Applied Materials (AMAT), Freeport-McMoRan (FCX), 3M (MMM), Allena Pharmaceuticals (ALNA), Costco Wholesale (COST), FireEye (FEYE), Intel (INTC), Xperi (XPER), Alibaba Group (BABA) and Delek US (DK). Who are Innophos' key executives? Innophos' management team includes the folowing people: Dr. Kim Ann Mink, Chairman, CEO & Pres (Age 59)Mr. Hermanus Kieftenbeld, Sr. VP & CFO (Age 53)Ms. Sherry Duff, Sr. VP and Chief Marketing & Technology Officer (Age 51)Mr. Joshua Horenstein, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 42)Ms. Amy Hartzell, Sr. VP of Supply Chain & Purchasing (Age 43) Who are Innophos' major shareholders? Innophos' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.01%), Dimensional Fund Advisors LP (5.61%), Frontier Capital Management Co. LLC (3.87%), Renaissance Technologies LLC (3.84%), Deprince Race & Zollo Inc. (2.59%) and Kennedy Capital Management Inc. (2.37%). View Institutional Ownership Trends for Innophos. Which major investors are selling Innophos stock? IPHS stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Deprince Race & Zollo Inc., JPMorgan Chase & Co., Kennedy Capital Management Inc., Renaissance Technologies LLC, California Public Employees Retirement System, Algert Global LLC and New York State Common Retirement Fund. View Insider Buying and Selling for Innophos. Which major investors are buying Innophos stock? IPHS stock was acquired by a variety of institutional investors in the last quarter, including Hotchkis & Wiley Capital Management LLC, Hotchkis & Wiley Capital Management LLC, Morgan Stanley, Goldman Sachs Group Inc., IndexIQ Advisors LLC, Hancock Whitney Corp, Victory Capital Management Inc. and Confluence Investment Management LLC. View Insider Buying and Selling for Innophos. How do I buy shares of Innophos? Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Innophos' stock price today? One share of IPHS stock can currently be purchased for approximately $28.33. How big of a company is Innophos? Innophos has a market capitalization of $557.25 million and generates $801.84 million in revenue each year. The specialty chemicals company earns $36.07 million in net income (profit) each year or $2.28 on an earnings per share basis. Innophos employs 1,485 workers across the globe. What is Innophos' official website? The official website for Innophos is http://www.innophos.com/. How can I contact Innophos? Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected] MarketBeat Community Rating for Innophos (NASDAQ IPHS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 293 (Vote Outperform)Underperform Votes: 280 (Vote Underperform)Total Votes: 573MarketBeat's community ratings are surveys of what our community members think about Innophos and other stocks. Vote "Outperform" if you believe IPHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: Ex-Dividend Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.